PL3515416T3 - Plaster zawierający nadmanganian potasu do leczenia zaburzenia skóry - Google Patents

Plaster zawierający nadmanganian potasu do leczenia zaburzenia skóry

Info

Publication number
PL3515416T3
PL3515416T3 PL17777332.2T PL17777332T PL3515416T3 PL 3515416 T3 PL3515416 T3 PL 3515416T3 PL 17777332 T PL17777332 T PL 17777332T PL 3515416 T3 PL3515416 T3 PL 3515416T3
Authority
PL
Poland
Prior art keywords
patch
treatment
potassium permanganate
skin disorder
disorder
Prior art date
Application number
PL17777332.2T
Other languages
English (en)
Inventor
David Houston
Keith Harding
Charles Heard
Original Assignee
Onya Therapeutics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onya Therapeutics Limited filed Critical Onya Therapeutics Limited
Publication of PL3515416T3 publication Critical patent/PL3515416T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
PL17777332.2T 2016-09-23 2017-09-21 Plaster zawierający nadmanganian potasu do leczenia zaburzenia skóry PL3515416T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1616223.2A GB201616223D0 (en) 2016-09-23 2016-09-23 Topical treatment patch
PCT/GB2017/052816 WO2018055376A1 (en) 2016-09-23 2017-09-21 Patch comprising potassium permanganate for the treatment of skin disorder

Publications (1)

Publication Number Publication Date
PL3515416T3 true PL3515416T3 (pl) 2024-01-15

Family

ID=57539902

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17777332.2T PL3515416T3 (pl) 2016-09-23 2017-09-21 Plaster zawierający nadmanganian potasu do leczenia zaburzenia skóry

Country Status (18)

Country Link
US (1) US11129800B2 (pl)
EP (1) EP3515416B1 (pl)
JP (1) JP7066692B2 (pl)
KR (1) KR102552765B1 (pl)
CN (1) CN109982688B (pl)
AU (1) AU2017332832B2 (pl)
DK (1) DK3515416T3 (pl)
ES (1) ES2954142T3 (pl)
GB (1) GB201616223D0 (pl)
HU (1) HUE063088T2 (pl)
IL (1) IL265581B2 (pl)
MX (1) MX386552B (pl)
MY (1) MY200120A (pl)
PL (1) PL3515416T3 (pl)
PT (1) PT3515416T (pl)
RU (1) RU2770064C2 (pl)
WO (1) WO2018055376A1 (pl)
ZA (1) ZA201902228B (pl)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3839246A (en) * 1973-08-09 1974-10-01 Gen Electric Two-part room temperature vulcanizable systems
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
JPS59104314A (ja) * 1982-11-09 1984-06-16 Hisamitsu Pharmaceut Co Inc 新規貼付薬
JP2659961B2 (ja) * 1986-08-18 1997-09-30 中外製薬株式会社 経皮吸収貼付剤
US5792090A (en) * 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
JPH10158155A (ja) * 1996-11-29 1998-06-16 Tac Medical Kk 貼付剤
RU2276998C2 (ru) * 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
US20030180281A1 (en) * 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
JP2004321785A (ja) * 2003-04-07 2004-11-18 Ube Ind Ltd 医療用パッチ及びその製造方法
EP1713450B1 (en) * 2004-01-30 2021-10-06 Corium, Inc. Rapidly dissolving film for delivery of an active agent
AU2006209239A1 (en) * 2005-01-27 2006-08-03 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrophilic biocompatible adhesive formulations and uses
JP2006248996A (ja) * 2005-03-10 2006-09-21 Nitto Denko Corp 経皮吸収型貼付剤
DE102006025282A1 (de) * 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
WO2013162723A1 (en) * 2012-04-27 2013-10-31 Dow Corning Corporation Topical formulation compositions containing silicone based excipients to deliver actives to a substrate
CN103819799B (zh) * 2014-03-07 2016-02-24 福州大学 一种聚合物/高锰酸钾复合薄膜及其制备方法
WO2016131096A1 (en) * 2015-02-16 2016-08-25 Ctm@Crc Ltd. Methods and products for delivering cells
EP3446693B1 (en) * 2015-02-19 2020-11-11 Hiantis S.r.l. Pharmaceutical compositions and formulations comprising aluminium acetate for topical application with astringent and antimicrobial effect
EP3088009B1 (en) * 2015-04-28 2018-07-18 DiCosmo, Frank Antimicrobial adhesive dressings

Also Published As

Publication number Publication date
US11129800B2 (en) 2021-09-28
WO2018055376A1 (en) 2018-03-29
HUE063088T2 (hu) 2023-12-28
RU2019112100A3 (pl) 2020-12-11
RU2019112100A (ru) 2020-10-23
CN109982688A (zh) 2019-07-05
CN109982688B (zh) 2023-08-15
MX2019003347A (es) 2019-10-07
RU2770064C2 (ru) 2022-04-14
IL265581B (en) 2022-12-01
DK3515416T3 (da) 2023-09-04
US20190224133A1 (en) 2019-07-25
PT3515416T (pt) 2023-09-07
KR102552765B1 (ko) 2023-07-10
BR112019005722A8 (pt) 2023-04-11
CA3037807A1 (en) 2018-03-29
AU2017332832A1 (en) 2019-04-18
JP2019533648A (ja) 2019-11-21
ES2954142T3 (es) 2023-11-20
IL265581A (en) 2019-05-30
BR112019005722A2 (pt) 2019-07-09
JP7066692B2 (ja) 2022-05-13
KR20190080869A (ko) 2019-07-08
AU2017332832B2 (en) 2023-04-27
MY200120A (en) 2023-12-08
IL265581B2 (en) 2023-04-01
MX386552B (es) 2025-03-11
EP3515416B1 (en) 2023-06-07
ZA201902228B (en) 2022-12-21
GB201616223D0 (en) 2016-11-09
EP3515416A1 (en) 2019-07-31

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
IL274865A (en) Treatment methods with asparaginase
ZA201705673B (en) Methods for treating skin
SG10202007559PA (en) Skin treatment apparatus
PL3215219T3 (pl) System do zabiegów na skórze
IL257908A (en) Methods for the treatment of epilepsy
ZA201705847B (en) Treatment of pain
SG11201708399WA (en) Methods of treating diseases
GB201409363D0 (en) Skin cancer treatment
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201602802D0 (en) Method of treatment
ZA201807325B (en) Treatment of skin lesions
IL258316A (en) A combination of trazodone and gabapentin for the treatment of pain
IL255012A0 (en) Preparations and methods for treating skin conditions
EP3271017A4 (en) Treatment of skin conditions
ZA201902228B (en) Patch comprising potassium permanganate for the treatment of skin disorder
GB201512139D0 (en) Methods of treatment
GB201518002D0 (en) Ketamine for the treatment of somatoform pain disorder
GB201703768D0 (en) Skin treatment methods
GB201703734D0 (en) Skin treatment methods
GB201404610D0 (en) Preparation and method for the treatment of skin
HK40006632A (en) Treatment of pain
AU2015900943A0 (en) Treatment of skin conditions
GB201602011D0 (en) Treating skin disorders
GB201613350D0 (en) Treatment of hyperpigmentation